Montelukast
Singulair 10 and Singulair are different trade names for the same medicine.
Singulair 10 is a leukotriene receptor antagonist that blocks the action of substances called leukotrienes.
Leukotrienes cause narrowing and swelling of the airways and also cause allergy symptoms. By blocking the action of leukotrienes, Singulair 10 relieves asthma symptoms, helps control asthma, and relieves symptoms of seasonal allergies (also known as hay fever or seasonal allergic rhinitis).
The doctor has prescribed Singulair 10 for the treatment of asthma, to prevent the occurrence of asthma symptoms during the day and at night.
The doctor will determine how to take Singulair 10, depending on the symptoms and severity of asthma in the patient.
Asthma is a chronic disease. In asthma, there are:
Seasonal allergies (also known as hay fever or seasonal allergic rhinitis) are allergic reactions of the body, often caused by airborne tree, grass, and weed pollen. Typical symptoms of seasonal allergies may include: feeling of nasal congestion, runny nose; itching of the nose; sneezing; tearing, swelling, redness, and itching of the eyes.
You should inform your doctor about any current or past illnesses and allergies.
You should discuss this with your doctor or pharmacist before starting to take Singulair 10.
You should inform the patient that in adults, adolescents, and children treated with Singulair 10, various neuropsychiatric events (such as changes in behavior and mood) have occurred (see section 4). If the patient experiences such symptoms while taking Singulair 10, they should consult their doctor.
This medicine should not be used in children under 15 years of age. For children and adolescents under 18 years of age, other forms of this medicine are available, suitable for the patient's age.
You should tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take, including those available without a prescription. Some medicines may affect the action of Singulair 10 or Singulair 10 may affect the action of other medicines you are taking. Before taking Singulair 10, you should inform your doctor if you are taking:
Singulair 10, 10 mg coated tablets, can be taken with or without food.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking Singulair 10. Pregnancy Your doctor will assess whether you can take Singulair 10 during this period. Breastfeeding It is not known whether Singulair 10 passes into breast milk. If you are breastfeeding or plan to breastfeed, you should consult your doctor before taking Singulair 10.
You should not expect Singulair 10 to affect your ability to drive or use machines. However, individual reactions to the medicine may vary. Some side effects (such as dizziness and drowsiness), which have been reported during treatment with Singulair 10, may affect your ability to drive or use machines.
If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine. The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means that the medicine is considered "sodium-free".
This medicine should always be taken as directed by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
The recommended dose is one 10 mg coated tablet once daily, in the evening. You should ensure that the patient taking Singulair 10 does not take other medicines that contain the same active substance, montelukast. This medicine is intended for oral use. Singulair 10 can be taken with or without food.
You should immediately consult your doctor. In most cases of overdose, no side effects have been observed. In cases of overdose in children and adults, the following symptoms have been most commonly observed: abdominal pain, drowsiness, excessive thirst, headache, vomiting, and hyperactivity.
Singulair 10 should be taken as directed by your doctor. However, if you miss a dose, you should return to your usual dosing schedule - one tablet once daily. You should not take a double dose to make up for the missed dose.
Singulair 10 is effective in treating asthma only when taken regularly. It is important to continue taking Singulair 10 for as long as your doctor has prescribed. This will help keep your asthma under control. If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, Singulair 10 can cause side effects, although not everybody gets them. During clinical trials with Singulair 10, 10 mg coated tablets, the most commonly reported side effects (which may occur in less than 1 in 10 people) that were considered to be related to Singulair 10 were:
You should immediately consult your doctorif you experience any of the following side effects, which may be severe and require immediate medical attention. Uncommon (may occur in less than 1 in 100 people):
Rare (may occur in less than 1 in 1,000 people):
Very rare (may occur in less than 1 in 10,000 people):
Very common (may occur in more than 1 in 10 people):
Common (may occur in less than 1 in 10 people):
Uncommon (may occur in less than 1 in 100 people):
Rare (may occur in less than 1 in 1,000 people):
Very rare (may occur in less than 1 in 10,000 people):
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Singulair 10 tablets are beige, square with rounded edges, coated tablets with the inscription SINGULAIR on one side and MSD 117 on the other. Al/Al blisters in packs of 14 or 28 tablets in a cardboard box. For more detailed information, you should contact the marketing authorization holder or the parallel importer.
N.V. Organon, Kloosterstraat 6, 5349 AB Oss, Netherlands
Merck Sharp & Dohme B.V., Waarderweg 39, 2031 BN Haarlem, Netherlands, Schering-Plough Labo NV, Industriepark 30, 2220 Heist-op-den-Berg, Belgium
Medezin Sp. z o.o., ul. Zbąszyńska 3, 91-342 Łódź
Medezin Sp. z o.o., ul. Zbąszyńska 3, 91-342 Łódź, CEFEA Sp. z o.o. Sp. komandytowa, ul. Działkowa 56, 02-234 Warsaw, SHIRAZ PRODUCTIONS Sp. z o.o., ul. Tymiankowa 24/28, 95-054 Ksawerów, CANPOLAND SPÓŁKA AKCYJNA, ul. Beskidzka 190, 91-610 Łódź, Marketing authorization number in the Czech Republic, the country of export: 14/351/99-C
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.